Cortical spreading depression in traumatic brain injuries: Is there a role for astrocytes?

Neuroscience Letters

Volumn 565, Issue , 2014, Pages 2-6

  Torrente, Daniel ^a   Cabezas, Ricardo ^a   Avila, Marco Fidel ^a   García Segura, Luis Miguel ^b   Barreto, George E ^a   Guedes, Rubem Carlos Araújo ^c  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b INSTITUTO CAJAL   (Spain)

^c Federal University of Pernambuco   (Brazil)

Author keywords

Astrocytes; CSD; Neurons; TBI

Indexed keywords

EXCITATORY AMINO ACID; REACTIVE OXYGEN METABOLITE;

ASTROCYTE; BRAIN PROTECTION; CELL FUNCTION; CELL SURVIVAL; ENERGY; HUMAN; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPREADING CORTICAL DEPRESSION; TRAUMATIC BRAIN INJURY;

ASTROCYTES; CSD; NEURONS; TBI;

ANIMALS; ASTROCYTES; BRAIN INJURIES; CELL SURVIVAL; CORTICAL SPREADING DEPRESSION; ENERGY METABOLISM; EXCITATORY AMINO ACIDS; HUMANS; NEURONS; REACTIVE OXYGEN SPECIES;

EID: 84897029443     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.058     Document Type: Review

References (67)

1. Leão A.A.P. Spreading depression of activity in the cerebral cortex. Journal of Neurophysiology 1944, 7:359-390.
2. Somjen G.G. Aristides Leao's discovery of cortical spreading depression. Journal of Neurophysiology 2005, 94:2-4.
3. Somjen G.G. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiological Reviews 2001, 81:1065-1096.
4. Dreier J.P., Woitzik J., Fabricius M., Bhatia R., Major S., Drenckhahn C., Lehmann T.N., Sarrafzadeh A., Willumsen L., Hartings J.A., Sakowitz O.W., Seemann J.H., Thieme A., Lauritzen M., Strong A.J. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006, 129:3224-3237.
5. Dreier J.P. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nature Medicine 2011, 17:439-447.
6. Hablitz J.J., Heinemann U. Alterations in the microenvironment during spreading depression associated with epileptiform activity in the immature neocortex. Developmental Brain Research 1989, 46:243-252.
7. Lauritzen M., Dreier J.P., Fabricius M., Hartings J.A., Graf R., Strong A.J. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism 2011, 31:17-35.
8. Miura R.M., Huang H., Wylie J.J. Cortical spreading depression: an enigma. European Physical Journal Special Topics 2007, 147:287-302.
9. Cui Y., Li Q.H., Yamada H., Watanabe Y., Kataoka Y. Chronic degeneration of dorsal raphe serotonergic neurons modulates cortical spreading depression: a possible pathophysiology of migraine. Journal of Neuroscience Research 2013, 91:737-744.
10. Anderova M., Kubinova S., Mazel T., Chvatal A., Eliasson C., Pekny M., Sykova E. Effect of elevated K(+), hypotonic stress, and cortical spreading depression on astrocyte swelling in GFAP-deficient mice. Glia 2001, 35:189-203.
11. 2+ waves and spreading depression in the mouse neocortex. Journal of Neuroscience 2003, 23:9888-9896.
12. Grafstein B. Subverting the hegemony of the synapse: complicity of neurons, astrocytes, and vasculature in spreading depression and pathology of the cerebral cortex. Brain Research Reviews 2011, 66:123-132.
13. Du F., Wu X.M., Gong Q., He X., Ke Y. Hyperthermia conditioned astrocyte-cultured medium protects neurons from ischemic injury by the up-regulation of HIF-1 alpha and the increased anti-apoptotic ability. European Journal of Pharmacology 2011, 666:19-25.
14. Wu X., Zhou C., Du F., Lu Y., Peng B., Chen L., Zhu L. Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion. Neurochemistry International 2013, 62:157-164.
15. Giordano G., Kavanagh T.J., Costa L.G. Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology 2009, 30:326-329.
16. Kimelberg H.K., Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010, 7:338-353.
17. Stewart R.M., Rosenberg R.N. Physiology of glia: glial-neuronal interactions. International Review of Neurobiology 1979, 21:275-309.
18. Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
19. Tower D.B., Young O.M. The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. Journal of Neurochemistry 1973, 20:269-278.
20. Orkand R.K. Introductory remarks glial-interstitial fluid exchange. Annals of the New York Academy of Sciences 1986, 481:269-272.
21. Ransom B.R., Sontheimer H. The neurophysiology of glial cells. Journal of Clinical Neurophysiology 1992, 9:224-251.
22. Basarsky T.A., Duffy S.N., Andrew R.D., MacVicar B.A. Imaging spreading depression and associated intracellular calcium waves in brain slices. Journal of Neuroscience 1998, 18:7189-7199.
23. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973.
24. Lian X.Y., Stringer J.L. Energy failure in astrocytes increases the vulnerability of neurons to spreading depression. European Journal of Neuroscience 2004, 19:2446-2454.
25. Bennett G.S., Edelman G.M. Amino acid incorporation into rat brain proteins during spreading cortical depression. Science 1969, 163:393-395.
26. Mies G., Paschen W. Regional changes of blood flow, glucose, and ATP content determined on brain sections during a single passage of spreading depression in rat brain cortex. Experimental Neurology 1984, 84:249-258.
27. Cheng G., Kong R.H., Zhang L.M., Zhang J.N. Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. British Journal of Pharmacology 2012, 167:699-719.
28. Gjedde A., Hansen A.J., Quistorff B. Blood-brain glucose transfer in spreading depression. Journal of Neurochemistry 1981, 37:807-812.
29. Freeman M.R. Specification and morphogenesis of astrocytes. Science 2010, 330:774-778.
30. Sidoryk-Wegrzynowicz M., Wegrzynowicz M., Lee E., Bowman A.B., Aschner M. Role of astrocytes in brain function and disease. Toxicologic Pathology 2011, 39:115-123.
31. Myer D.J., Gurkoff G.G., Lee S.M., Hovda D.A., Sofroniew M.V. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
32. Dienel G.A., Hertz L. Glucose and lactate metabolism during brain activation. Journal of Neuroscience Research 2001, 66:824-838.
33. Barreto G.E., Gonzalez J., Torres Y., Morales L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neuroscience Research 2011, 71:107-113.
34. Zielke H.R., Zielke C.L., Baab P.J. Direct measurement of oxidative metabolism in the living brain by microdialysis: a review. Journal of Neurochemistry 2009, 109(Suppl. 1):24-29.
35. Chen T., Qian Y.Z., Di X., Rice A., Zhu J.P., Bullock R. Lactate/glucose dynamics after rat fluid percussion brain injury. Journal of Neurotrauma 2000, 17:135-142.
36. Karunasinghe R.N., Lipski J. Oxygen and glucose deprivation (OGD)-induced spreading depression in the Substantia Nigra. Brain Research 2013, 1527:209-221.
37. Piilgaard H., Lauritzen M. Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. Journal of Cerebral Blood Flow and Metabolism 2009, 29:1517-1527.
38. Wender R., Brown A.M., Fern R., Swanson R.A., Farrell K., Ransom B.R. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. Journal of Neuroscience 2000, 20:6804-6810.
39. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. New England Journal of Medicine 2002, 346:557-563.
40. Arun P., Ariyannur P.S., Moffett J.R., Xing G., Hamilton K., Grunberg N.E., Ives J.A., Namboodiri A.M. Metabolic acetate therapy for the treatment of traumatic brain injury. Journal of Neurotrauma 2010, 27:293-298.
41. Choi H.A., Badjatia N., Mayer S.A. Hypothermia for acute brain injury - mechanisms and practical aspects. Nature Reviews Neurology 2012, 8:214-222.
42. Shao Z.H., Sharp W.W., Wojcik K.R., Li C.Q., Han M., Chang W.T., Ramachandran S., Li J., Hamann K.J., Vanden Hoek T.L. Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants. American Journal of Physiology 2010, 298:H2164-H2173.
43. Suarez I., Bodega G., Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochemistry International 2002, 41:123-142.
44. Richter F., Lehmenkuhler A. Cortical spreading depression (CSD): a neurophysiological correlate of migraine aura. Schmerz (Berlin, Germany) 2008, 22:544-546. 548-550.
45. de Lima D.S., Maia L.M., Barboza E.A., Duarte R.A., Souza L.S., Guedes R.C.A. l-Glutamine supplementation during the lactation period facilitates cortical spreading depression in well-nourished and early-malnourished rats. Life Sciences 2009, 85:241-247.
46. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
47. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
48. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochemistry International 2007, 51:333-355.
49. Maragakis N.J., Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiology of Disease 2004, 15:461-473.
50. Fumagalli E., Funicello M., Rauen T., Gobbi M., Mennini T. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. European Journal of Pharmacology 2008, 578:171-176.
51. Fontana A.C., de Oliveira Beleboni R., Wojewodzic M.W., Ferreira Dos Santos W., Coutinho-Netto J., Grutle N.J., Watts S.D., Danbolt N.C., Amara S.G. Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom. Molecular Pharmacology 2007, 72:1228-1237.
52. Bunch L., Erichsen M.N., Jensen A.A. Excitatory amino acid transporters as potential drug targets. Expert Opinion on Therapeutic Targets 2009, 13:719-731.
53. Faden A.I., Demediuk P., Panter S.S., Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989, 244:798-800.
54. Smith J.M., Bradley D.P., James M.F., Huang C.L. Physiological studies of cortical spreading depression. Biological Reviews of the Cambridge Philosophical Society 2006, 81:457-481.
55. Marklund N., Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. British Journal of Pharmacology 2011, 164:1207-1229.
56. Walz W., Wuttke W.A. Independent mechanisms of potassium clearance by astrocytes in gliotic tissue. Journal of Neuroscience Research 1999, 56:595-603.
57. + in rat hippocampus. Journal of Neurophysiology 2002, 87:87-102.
58. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Letters 2001, 495:12-15.
59. Starkov A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Annals of the New York Academy of Sciences 2008, 1147:37-52.
60. Murphy M.P. How mitochondria produce reactive oxygen species. Biochemical Journal 2009, 417:1-13.
61. Mustafa A.G., Singh I.N., Wang J., Carrico K.M., Hall E.D. Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals. Journal of Neurochemistry 2010, 114:271-280.
62. Dringen R. Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000, 62:649-671.
63. Sims N.R., Nilsson M., Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. Journal of Bioenergetics and Biomembranes 2004, 36:329-333.
64. Maia L.M., Amancio-dos-Santos A., Duda-de-Oliveira D., Angelim M.K., Germano P.C., Santos S.F., Guedes R.C. l-Arginine administration during rat brain development facilitates spreading depression propagation: evidence for a dose- and nutrition-dependent effect. Nutritional Neuroscience 2009, 12:73-80.
65. Maier C.M., Hsieh L., Crandall T., Narasimhan P., Chan P.H. Evaluating therapeutic targets for reperfusion-related brain hemorrhage. Annals of Neurology 2006, 59:929-938.
66. Mustafa A.G., Wang J.A., Carrico K.M., Hall E.D. Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury. Journal of Neurochemistry 2011, 117:579-588.
67. Torrente D., Avila M., Cabezas R., Morales L., Gonzalez J., Samudio I., Barreto G. Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model. Human & Experimental Toxicology 2013, (in press). 10.1177/0960327113509659.